Literature DB >> 6341202

Invited review. Nervous system antigens.

D I Graham, D G Thomas, I Brown.   

Abstract

Some of the better characterized proteins (markers) of the nervous system are described. The availability of specific antibodies to these markers has allowed the localization and assay of the proteins in tissue and biological fluids. There is some evidence that autosensitization may occur. Clinical application of these markers includes the evaluation and prognostic significance after stroke and head injury. The diagnostic histopathological use of the markers in the investigation of various tumours is summarized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341202     DOI: 10.1111/j.1365-2559.1983.tb02212.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  5 in total

1.  An immunohistochemical study of glial and neuronal markers in primary neoplasms of the central nervous system.

Authors:  J A Royds; J W Ironside; C B Taylor; D I Graham; W R Timperley
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Immunocytochemical study of the distribution of S-100 protein in the parathyroid gland of rats and guinea pigs.

Authors:  M Zabel; J Surdyk; I Biela-Jacek
Journal:  Histochemistry       Date:  1986

3.  Antibodies to neurofilament protein and other brain proteins reveal the innervation of peripheral organs.

Authors:  G W Hacker; J M Polak; D R Springall; J Ballesta; A Cadieux; J Gu; J Q Trojanowski; D Dahl; P J Marangos
Journal:  Histochemistry       Date:  1985

4.  S-100 protein and neuron-specific enolase in parathyroid glands and C-cells of the thyroid.

Authors:  M Zabel; M Dietel
Journal:  Histochemistry       Date:  1987

5.  Human teratomas express differentiated neural antigens. An immunohistochemical study with anti-neurofilament, anti-glial filament, and anti-myelin basic protein monoclonal antibodies.

Authors:  J Q Trojanowski; W F Hickey
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.